Quarter Period Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7711914

Concept 2019-01-01 to
2019-03-31
2018-01-01 to
2018-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
275,650,000 JPY
53,753,000 JPY
Cost of sales
3,342,000 JPY
2,762,000 JPY
Gross profit (loss)
272,308,000 JPY
50,991,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
126,421,000 JPY
243,204,000 JPY
Operating profit (loss)
145,886,000 JPY
-192,213,000 JPY
Non-operating income
Interest income
51,000 JPY
27,000 JPY
Non-operating income
51,000 JPY
177,000 JPY
Non-operating expenses
Interest expenses
1,566,000 JPY
1,568,000 JPY
Non-operating expenses
2,020,000 JPY
3,590,000 JPY
Ordinary profit (loss)
143,918,000 JPY
-195,625,000 JPY
Extraordinary income
Extraordinary income
JPY
1,657,000 JPY
Profit (loss) before income taxes
143,918,000 JPY
-193,968,000 JPY
Income taxes - current
398,000 JPY
391,000 JPY
Income taxes
398,000 JPY
391,000 JPY
Profit (loss)
143,519,000 JPY
-194,360,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
-9,106,000 JPY
-10,082,000 JPY
Profit (loss) attributable to owners of parent
152,625,000 JPY
-184,277,000 JPY
Comprehensive income
143,519,000 JPY
-194,360,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
152,625,000 JPY
-184,277,000 JPY
Comprehensive income attributable to non-controlling interests
-9,106,000 JPY
-10,082,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.